Ferrous salt/folic acid
|Trade names||Fefol, Galfer FA, others|
|Defined daily dose||0.4 gram (by mouth)|
10 mg (parenteral)
|AHFS/Drugs.com||Multum Consumer Information|
Ferrous salt/folic acid is a supplement used to prevent iron deficiency and folic acid deficiency during pregnancy. It can also be used to treat iron deficiency anemia. It is a fixed dose combination of ferrous salt and folic acid. It is taken by mouth.
Ferrous salt/folic acid was approved for medical use in the United States as early as 1946. It is on the World Health Organization's List of Essential Medicines. The wholesale cost in the developing world is about 0.07 to 1.02 USD a month. It is not currently commercially available as a combination in the United States. In the United Kingdom, it costs the NHS about £2.64 to £4.25 per month.
- "WHOCC - ATC/DDD Index". www.whocc.no. Retrieved 18 September 2020. CS1 maint: discouraged parameter (link)
- World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. pp. 249–50. hdl:10665/44053. ISBN 9789241547659.
- "Fefol Spansule Capsules - Summary of Product Characteristics (SPC) - (eMC)". www.medicines.org.uk. 2 April 2013. Archived from the original on 20 December 2016. Retrieved 18 December 2016. CS1 maint: discouraged parameter (link)
- "Ferrous sulfate and folic acid medical facts from Drugs.com". www.drugs.com. Archived from the original on 21 December 2016. Retrieved 18 December 2016. CS1 maint: discouraged parameter (link)
- World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- "Ferrous Salt + Folic Acid". International Drug Price Indicator Guide. Retrieved 8 December 2016. CS1 maint: discouraged parameter (link)
- British national formulary : BNF 69 (69 ed.). British Medical Association. 2015. p. 661. ISBN 9780857111562.